Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy followed by fertility-sparing surgery for stage IB2 cervical cancer
NL-OMON60794Phase 2Recruiting
- Sponsor
- University Health Network
- Start
- Feb 2021
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin, paclitaxel and cisplatin in Cervical Cancer (CC), sponsored by University Health Network. Primary endpoint: Rate of functional uterus. Started Feb 2021; status: recruiting.
02
Drugs
carboplatinpaclitaxelcisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NL-OMON60794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60794.